logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

The net asset value per share of GOLDSTONE CAP (01160) at the end of May was approximately -0.002 Hong Kong dollars.

date
16:51 11/06/2026
avatar
GMT Eight
Goldstone Capital Group (01160) announced that as of May 31, 2026, the unaudited net asset value per share of the company is approximately 0.002 Hong Kong dollars.
GOLDSTONE CAP (01160) announced on May 31, 2026, the unaudited net asset value per share of the company was approximately 0.002 Hong Kong dollars.
Related Articles
HK Stock
On June 11, 7ROAD (00797) spent 1.575 million Hong Kong dollars to repurchase 1.5 million shares.
HK Stock
C FIN SERVICES (00605) granted a loan of HK$23 million.
China Stock
Anhui Huaren Health Pharmaceutical (301408.SZ): Application for the registration and listing approval of orally dissolved bromhexine hydrochloride has been accepted.
On June 11, 7ROAD (00797) spent 1.575 million Hong Kong dollars to repurchase 1.5 million shares.
HK Stock
C FIN SERVICES (00605) granted a loan of HK$23 million.
HK Stock
Anhui Huaren Health Pharmaceutical (301408.SZ): Application for the registration and listing approval of orally dissolved bromhexine hydrochloride has been accepted.
China Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.